Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics
- PMID: 10807560
- PMCID: PMC1637757
- DOI: 10.1289/ehp.00108s2307
Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics
Abstract
A physiologically based pharmacokinetic model for trichloroethylene (TCE) in rodents and humans was calibrated with published toxicokinetic data sets. A Bayesian statistical framework was used to combine previous information about the model parameters with the data likelihood, to yield posterior parameter distributions. The use of the hierarchical statistical model yielded estimates of both variability between experimental groups and uncertainty in TCE toxicokinetics. After adjustment of the model by Markov chain Monte Carlo sampling, estimates of variability for the animal or human metabolic parameters ranged from a factor of 1.5-2 (geometric standard deviation [GSD]). Uncertainty was of the same order as variability for animals and higher than variability for humans. The model was used to make posterior predictions for several measures of cancer risk. These predictions were affected by both uncertainties and variability and exhibited GSDs ranging from 2 to 6 in mice and rats and from 2 to 10 for humans.
Similar articles
-
Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics.Environ Health Perspect. 2000 May;108 Suppl 2(Suppl 2):275-82. doi: 10.1289/ehp.00108s2275. Environ Health Perspect. 2000. PMID: 10807558 Free PMC article.
-
Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach.Toxicol Appl Pharmacol. 2009 Nov 15;241(1):36-60. doi: 10.1016/j.taap.2009.07.032. Epub 2009 Aug 4. Toxicol Appl Pharmacol. 2009. PMID: 19660485
-
Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites.Regul Toxicol Pharmacol. 2006 Oct;46(1):63-83. doi: 10.1016/j.yrtph.2006.05.012. Epub 2006 Aug 4. Regul Toxicol Pharmacol. 2006. PMID: 16889879
-
Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.Environ Health Perspect. 2000 May;108 Suppl 2(Suppl 2):283-305. doi: 10.1289/ehp.00108s2283. Environ Health Perspect. 2000. PMID: 10807559 Free PMC article. Review.
-
Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.Regul Toxicol Pharmacol. 1997 Feb;25(1):26-42. doi: 10.1006/rtph.1996.1070. Regul Toxicol Pharmacol. 1997. PMID: 9056499 Review.
Cited by
-
Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data.Br J Clin Pharmacol. 2015 Jan;79(1):48-55. doi: 10.1111/bcp.12234. Br J Clin Pharmacol. 2015. PMID: 24033787 Free PMC article. Review.
-
Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics.Environ Health Perspect. 2000 May;108 Suppl 2(Suppl 2):275-82. doi: 10.1289/ehp.00108s2275. Environ Health Perspect. 2000. PMID: 10807558 Free PMC article.
-
Evaluation and calibration of high-throughput predictions of chemical distribution to tissues.J Pharmacokinet Pharmacodyn. 2017 Dec;44(6):549-565. doi: 10.1007/s10928-017-9548-7. Epub 2017 Oct 14. J Pharmacokinet Pharmacodyn. 2017. PMID: 29032447 Free PMC article.
-
A physiologically based pharmacokinetic model of rifampin in mice.Antimicrob Agents Chemother. 2013 Apr;57(4):1763-71. doi: 10.1128/AAC.01567-12. Epub 2013 Jan 28. Antimicrob Agents Chemother. 2013. PMID: 23357766 Free PMC article.
-
Physiologically based pharmacokinetic (PBPK) modeling of interstrain variability in trichloroethylene metabolism in the mouse.Environ Health Perspect. 2014 May;122(5):456-63. doi: 10.1289/ehp.1307623. Epub 2014 Feb 11. Environ Health Perspect. 2014. PMID: 24518055 Free PMC article.